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Identification of patients at increased risk of death due
to acute coronary syndrome (ACS) can add to risk stratifi-
cation and guide the next step in themanagement of those
patients. Altered HRV has been associated with adverse
outcomes in heart disease, but this has not been estab-
lished in patients with acute chest pain.This study aimed
to create a non-invasive, economical and risk-free method
in the clinical evaluation and diagnosis of significant CAD
among patients with unstable angina.Twenty-four-hour
Holter recordings of 100 patients with ACS were initiated
within 24 hours of admission at the emergency depart-
ment; stress ECG was done for all patients while coronary
angiography was done only for patients with abnormal
stress test. Time domain, frequency domain, and non-
linear HRV were examined.The mean SDNN was statisti-
cally significantly lower in patients with abnormal stress
test, many time and frequency domain HRV parameters
was statistically lower in patients with significant coronary
arteries obstruction.HRVmeasured close to theACSonset
may assist in risk stratification. HRV parameters may pro-
vide additional, incremental prognostic information to
established assessment guidelines and possible early
intervention in those patients.
http://dx.doi:10.1016/j.jsha.2016.04.049
TREATMENT OF ARRHYTHMIAS: ABLATION
49. Impact of atrial fibrillation on platelet-
predominate gene expression
W. Wysokinski
Mayo Clinic, Rochester, USA
Platelets retain cytoplasmic mRNA and are capable of
protein biosynthesis upon stimulation. We hypothesized
that changes in flow hemodynamics, and extracel- lular
matrix stimulation induced by non-valvular atrial fibrilla-
tion (NVAF) may impact platelet RNA content and there-
fore platelet activity in patients with this dysrhythmia.
Expression of platelet predominate genes was assessed in
consecutive NVAF patients before and 3–4 months after
catheter ablation of pulmonary veins (CAPV). Results were
compared to age and gendermatchednormal sinus rhythm
(NSR) controls. RNA from isolated platelets were reverse-
transcribed (Invitrogen), assayed against 22 genes (Taq-
Man) using real-time qPCR, and expressed as mean cycle
threshold (DCt) (ABI Prism 7700 Sequence Detection Sys-
tem) using beta-2-microglobulin as endogenous control.
All evaluated genes, except cathepsin A gene (CTSA),
showed lower expression (higher DCt) in 103 NVAF
patients compared to 55 NSR controls. At least 2-fold lower
expression was found in 12 genes. Within this group,
expression of insulin-like growth factor binding protein
acid labile subunit gene (IGFALS) was more than 16th fold
lower (more than four cycles; 17.0 ± 2.8 vs 12.5 ± 3.8,
p < .001) and non-muscle cofilin gene (CFL1), prostacyclin
receptor gene (PTGIR), and von Willebrand gene (VWF)
were 4-fold lower compared to NSR controls. After CAPV,
7 genes demonstrated increased expression including
IGFALS gene that showed 256-fold increase (8.3 ± 5.6 vs
16.6 ± 3.0, p < .001). Four genes had lower expression after
CAPV but only one, tubulin gene (TUBA4A) had it lower
by one cycle (2-fold). DD96 membrane associated protein
gene (PDZK1IP) showed significantly higher expression in
patients without recurrence of atrial fibrillation compared
to those with confirmed or suspected recurrence.The
altered flow hemodynamics associated with NVAF impacts
platelet RNA content. Of these, measurable differences of
IGFALS expression is notable. Changes of platelet gene
expression following sinus rhythm restoration underscores
the direct interaction between these two entities.
http://dx.doi:10.1016/j.jsha.2016.04.050
Intervention and surgery
CATHETER-BASED CORONARY INTERVENTIONS: EXPERI-
MENTAL NEW TECHNOLOGY
50. Primary PCI for STEMI patients at KACC: Has
patient’s access and hospital outcome improved
over the last 5 years?
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Primary PCI (pPCI) is Class1 indication to treat patients
(pts) with S-T elevation Myocardial Infarction (STEMI). In
2010, 56%of STEMIpts presented toKACCwere treatedwith
pPCI with hospital mortality of 2.3% compared to 11.3% for
those who did not qualify mainly due to late presentation.
We aim to compare pts access, reason for no access to pPCI
and hospital outcome 5 yrs on. Data from 2010 at KACC
showed relatively low access to pPCI for STEMI pts primarily
due to late presentation and initial thrombolysis. We believe
that pts access to pPCI would have improved over the last 5
years due to improved public awareness and expanding
evidenced-based health provision. This is a retrospective
study to analyze and compare data for STEMI pts during
2010 (G1 = 223 pts) and those treated between August 2014
and August 2015 (G2 = 288 pts). We compared demographic
and baseline characteristics, pts access, reason for no access
and hospital mortality for the two groups. We used
student-t test to compare continuous variables and Chi-
square test to compare categorical onesOf the 288 pts in G2,
247 pts (85%) were males with average age of 57 yrs. 49%
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